• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

漱口水可否作为 SARS-CoV-2 患者的辅助治疗手段?一项系统评价的评估。

Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.

机构信息

Department of Oral and Maxillofacial Pathology, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, India.

Department of Medical Surgical Nursing, Manipal College of Nursing, Manipal Academy of Higher Education, Manipal, India.

出版信息

Int J Dent Hyg. 2022 Feb;20(1):136-144. doi: 10.1111/idh.12555. Epub 2021 Oct 29.

DOI:10.1111/idh.12555
PMID:34628705
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8653299/
Abstract

OBJECTIVE

A wide variety of mouth rinses are available to combat micro-organisms in the oral cavity. At the present global pandemic, the need of the hour is to control the viral infection due to the novel corona virus SARS-COV-2, as its port of entry is through the receptors located in the oral and pharyngeal mucosa. This systematic literature review focuses on the in vivo studies [randomized control trials (RCTs)] done on the efficacy of existing mouth rinses which have been used in reducing the viral loads.

METHODS

The electronic database which includes PubMed-MEDLINE, Google scholar, Scopus, Web of Science, EMBASE, ProQuest and CINAHL was searched from December 2019 to June 2021 with appropriate Medical Subject Headings (MeSH) terms and Boolean operators. Two reviewers independently reviewed the abstracts.

RESULTS

Of the 2438 retrieved titles, 905 remained after removing duplicates. Twelve articles were eligible to be included in this review of which seven were randomized with adequate sample size.

CONCLUSIONS

Mouth washes containing povidone iodine and chlorhexidine decrease the viral load transiently. Large amount of in vivo studies are of paramount importance, especially RCTs, to prove the efficacy of these mouth rinses.

摘要

目的

有多种漱口液可用于对抗口腔中的微生物。在当前的全球大流行中,当务之急是控制新型冠状病毒 SARS-COV-2 的病毒感染,因为它的入口是通过位于口腔和咽粘膜上的受体。本系统文献综述侧重于已发表的体内研究[随机对照试验(RCT)],这些研究评估了现有的漱口液在降低病毒载量方面的功效。

方法

从 2019 年 12 月至 2021 年 6 月,使用适当的医学主题词(MeSH)术语和布尔运算符,对包括 PubMed-MEDLINE、Google Scholar、Scopus、Web of Science、EMBASE、ProQuest 和 CINAHL 在内的电子数据库进行了检索。两名审查员独立审查了摘要。

结果

在检索到的 2438 篇标题中,去除重复项后仍有 905 篇。有 12 篇文章符合纳入本综述的条件,其中 7 篇为随机对照试验,且样本量充足。

结论

含有聚维酮碘和洗必泰的漱口液可暂时降低病毒载量。大量的体内研究至关重要,特别是 RCT,以证明这些漱口液的功效。

相似文献

1
Could mouth rinses be an adjuvant in the treatment of SARS-CoV-2 patients? An appraisal with a systematic review.漱口水可否作为 SARS-CoV-2 患者的辅助治疗手段?一项系统评价的评估。
Int J Dent Hyg. 2022 Feb;20(1):136-144. doi: 10.1111/idh.12555. Epub 2021 Oct 29.
2
Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of and Studies.漱口水和鼻腔喷雾剂在 SARS-CoV-2 灭活中的效果:和研究的系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Sep 25;19(19):12148. doi: 10.3390/ijerph191912148.
3
Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers.口腔预处理冲洗液在预防牙科医护人员通过气溶胶传播传染性疾病中的应用。
Cochrane Database Syst Rev. 2022 Aug 22;8(8):CD013826. doi: 10.1002/14651858.CD013826.pub2.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
The effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load: A systematic review.含漱剂对严重急性呼吸综合征冠状病毒 2 病毒载量的影响:系统评价。
J Am Dent Assoc. 2022 Jul;153(7):635-648.e16. doi: 10.1016/j.adaj.2021.12.007. Epub 2021 Dec 30.
10
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.

引用本文的文献

1
Effectiveness of mouthwashes to reduce the SARS-COV-2 load in saliva of adults with diagnosis of COVID-19: Systematic review and meta-analysis.含漱液对降低确诊为COVID-19的成年人唾液中SARS-CoV-2载量的有效性:系统评价和荟萃分析。
J Clin Exp Dent. 2025 Jan 1;17(1):e96-e107. doi: 10.4317/jced.62196. eCollection 2025 Jan.
2
Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases.防腐剂:预防和管理冠状病毒疾病的一支快速起效的第三种力量。
Curr Res Microb Sci. 2024 Oct 16;7:100293. doi: 10.1016/j.crmicr.2024.100293. eCollection 2024.
3
Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.三种抗菌漱口液对降低住院患者唾液中 SARS-CoV-2 病毒载量的疗效:一项随机对照的初步研究。
Sci Rep. 2023 Aug 4;13(1):12647. doi: 10.1038/s41598-023-39308-x.
4
effect of mouthwashes on viable viral load of SARS-CoV-2 in saliva: a pilot study.漱口水对唾液中新冠病毒活病毒载量的影响:一项初步研究。
J Oral Microbiol. 2023 Apr 11;15(1):2198432. doi: 10.1080/20002297.2023.2198432. eCollection 2023.
5
A Cross-Sectional, Questionnaire-Based Survey on Air Infection Control among Romanian People.罗马尼亚民众空气感染控制的横断面、基于问卷的调查。
Int J Environ Res Public Health. 2022 Sep 25;19(19):12140. doi: 10.3390/ijerph191912140.
6
Transparency of COVID-19-Related Research in Dental Journals.牙科期刊中与 COVID-19 相关研究的透明度
Front Oral Health. 2022 Apr 6;3:871033. doi: 10.3389/froh.2022.871033. eCollection 2022.
7
Relationship between Recovery from COVID-19-Induced Smell Loss and General and Oral Health Factors.COVID-19 相关嗅觉丧失的恢复与一般和口腔健康因素的关系。
Medicina (Kaunas). 2022 Feb 14;58(2):283. doi: 10.3390/medicina58020283.

本文引用的文献

1
Estimating salivary carriage of severe acute respiratory syndrome coronavirus 2 in nonsymptomatic people and efficacy of mouthrinse in reducing viral load: A randomized controlled trial.估算无症状人群中严重急性呼吸综合征冠状病毒 2 的唾液携带情况以及漱口液降低病毒载量的效果:一项随机对照试验。
J Am Dent Assoc. 2021 Nov;152(11):903-908. doi: 10.1016/j.adaj.2021.05.021. Epub 2021 Jun 11.
2
In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.体内评价洗必泰及聚维酮碘漱口液对唾液 SARS-CoV-2 的病毒杀灭效果:一项随机对照临床试验。
J Evid Based Dent Pract. 2021 Sep;21(3):101584. doi: 10.1016/j.jebdp.2021.101584. Epub 2021 Apr 28.
3
Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.使用漱口水降低唾液中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)载量:一项随机试点临床试验。
Heliyon. 2021 Jun;7(6):e07346. doi: 10.1016/j.heliyon.2021.e07346. Epub 2021 Jun 18.
4
Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.使用抗病毒漱口水作为无症状至轻度 COVID-19 成人 SARS-CoV-2 传播的屏障措施:一项多中心、随机、双盲对照试验。
Clin Microbiol Infect. 2021 Oct;27(10):1494-1501. doi: 10.1016/j.cmi.2021.05.028. Epub 2021 May 24.
5
Oral antiseptics against coronavirus: in-vitro and clinical evidence.抗冠状病毒的口腔抗菌剂:体外及临床证据
J Hosp Infect. 2021 Jul;113:30-43. doi: 10.1016/j.jhin.2021.04.004. Epub 2021 Apr 15.
6
Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX and BacterX Pro.通过使用漱口水ViruProX和BacterX Pro治疗使严重急性呼吸综合征冠状病毒2(SARS-CoV-2)失活
Microorganisms. 2021 Mar 3;9(3):521. doi: 10.3390/microorganisms9030521.
7
Use of chlorhexidine to eradicate oropharyngeal SARS-CoV-2 in COVID-19 patients.使用洗必泰清除 COVID-19 患者口咽部的 SARS-CoV-2。
J Med Virol. 2021 Jul;93(7):4370-4373. doi: 10.1002/jmv.26954. Epub 2021 Apr 1.
8
Study on the COVID-19 infection status, prevention and control strategies among people entering Shenzhen.深圳入境人员新冠病毒感染状况及防控策略研究
BMC Public Health. 2021 Mar 20;21(1):551. doi: 10.1186/s12889-021-10548-8.
9
COVID-19 and Oral Surgery: A narrative review of preoperative mouth rinses.新型冠状病毒肺炎与口腔外科手术:术前漱口液的叙述性综述
Acta Stomatol Croat. 2020 Dec;54(4):431-441. doi: 10.15644/asc54/4/10.
10
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection.通过对大型药物重定位化合物库进行高通量筛选获得的 SARS-CoV-2 细胞病变数据集。
Sci Data. 2021 Feb 26;8(1):70. doi: 10.1038/s41597-021-00848-4.